Gilead Sciences, 10% Owner: Kyverna Therapeutics KYTX Buy · Filed 24/02/13

Trade details

Type: Insider buy
Amount: $20,020,000
Shares · price: 910,000 sh · $22.00 a share
Held after: 4,126,119 sh
Stock: Kyverna Therapeutics KYTX
Person: Gilead Sciences10% Owner
Trade date: 24/02/12
Filed: 24/02/13
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 13 insiders
Holding change: +28.3%

Kyverna Therapeutics trades, last 26 weeks

What else happened in Kyverna Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/13~24/03/13

Gilead Sciences's recent trades

Gilead Sciences10% Owner
BuyAssembly Biosciences
Buy
Assembly Biosciences
ASMB
2,295,920 sh
price in footnote
2,295,920 sh
Filed 25/10/03
Traded 25/08/08
Gilead Sciences10% Owner
BuyArcus Biosciences
Buy
Arcus Biosciences
RCUS
$15M
1,363,636 sh
$15M
Filed 25/02/20
Traded 25/02/18
Gilead Sciences10% Owner
BuyAssembly Biosciences
Buy
Assembly Biosciences
ASMB
$20.1M
940,499 sh
$20.1M
Filed 24/12/23
Traded 24/12/19
Gilead Sciences10% Owner
BuyXilio Therapeutics
Buy
Xilio Therapeutics
XLO
$1.8M
1,759,978 sh
$1.8M
Filed 24/12/19
Traded 24/12/18
Gilead Sciences10% Owner
BuyAssembly Biosciences
Buy
Assembly Biosciences
ASMB
179,500 sh
price in footnote
179,500 sh
Filed 24/06/20
Traded 24/06/17